0
Eiger BioPharmaceuticals, Inc.  Banner Image

Eiger BioPharmaceuticals, Inc.

  • Ticker EIGR
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Eiger BioPharmaceuticals, Inc.  Logo Image
  • 11-50 Employees
  • Based in Palo Alto, California
Eiger is a biopharmaceutical company focused on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. Eiger's pipeline includes preclinical NCEs from discovery as well repurposed clinical Rx agents shown to possess antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses. http://www.eigerbio.com
REPORT RATINGS
4.8 / 5.0 (94)

Eiger BioPharmaceuticals, Inc. reports have an aggregate usefulness score of 4.8 based on 94 reviews.

Eiger BioPharmaceuticals, Inc.

Most Recent Annual Report

Eiger BioPharmaceuticals, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Eiger BioPharmaceuticals, Inc.  Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!